{
  "pmcid": "10364767",
  "abstract": "300-word version:\n\nTitle: A Randomised Controlled Trial of Antibiotics Versus Placebo for Uncomplicated Acute Appendicitis\n\nBackground: This double-blind, placebo-controlled, superiority randomised controlled trial (RCT) aimed to assess the efficacy of antibiotics compared to placebo in adults with CT-confirmed uncomplicated acute appendicitis.\n\nMethods: Conducted at five hospitals, participants aged 18-60 years with uncomplicated acute appendicitis were randomised 1:1 to receive either antibiotics (intravenous ertapenem followed by oral levofloxacin and metronidazole) or placebo. The primary outcome was treatment success, defined as resolution of appendicitis without appendicectomy within 10 days. Randomisation was stratified by centre, and allocation was concealed. Both patients and clinicians were blinded.\n\nResults: From May 2017 to September 2020, 72 patients were randomised (35 to antibiotics, 31 to placebo). Six were excluded post-randomisation due to early consent withdrawal or protocol violation. The treatment success rate was 97% (34/35) for antibiotics and 87% (27/31) for placebo, with a non-significant difference of 10% (90% CI -0.9 to 21; p = 0.142). No deaths occurred, and adverse events were similar between groups. Pain scores decreased significantly in both groups, and no complications related to appendicectomy were reported within the 10-day follow-up.\n\nInterpretation: The lack of statistical superiority of antibiotics over placebo suggests that a non-inferiority trial is warranted to further explore the role of supportive care in uncomplicated acute appendicitis. Trial registration: EudraCT 2015-003634-26, NCT03234296. Funding: Sigrid Jus√©lius Foundation, Academy of Finland, Mary and Georg C. Ehrnrooth Foundation.",
  "word_count": 235
}